Michael Guggemos

Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes.

Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes.

Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes.

Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes.

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.